Angiotensin ii receptor blocking imidazoles and combinations...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/208, 260/300

C07D 233/54 (2006.01) A61K 31/415 (2006.01) C07D 233/68 (2006.01) C07D 233/70 (2006.01) C07D 233/84 (2006.01) C07D 233/90 (2006.01) C07D 401/06 (2006.01) C07D 403/04 (2006.01) C07D 403/06 (2006.01) C07D 403/10 (2006.01) C07D 403/14 (2006.01) C07D 405/06 (2006.01) C07D 405/10 (2006.01) C07D 409/10 (2006.01) C07D 521/00 (2006.01) C07F 9/6506 (2006.01)

Patent

CA 1338238

The present invention relates to substituted imidazoles, useful in pharmaceutical compositions, especially diuretics and non-steroidal anti-inflamatory drugs. The imidazoles have the formula: Image (I) wherein: R1 is 4-CO2H; 4-CO2R9; Image ; -SO3H; C(CF3)2OH; Image ; -PO3H; Image ; 4-NHSO2CH3; 4-NHSO2CF3; -CONHOR12; SO2NH2; Image ; Image ; Image ; Image ; Image ; Image ; Image ; Image ; Image ; 4 - CONHNHS~F3; Image ; (?-isomer) Image ; Image ; Image ; Image ; Image ; Image ; or Image ; R2 is H; Cl; Br; I; F; NO2; CN; alkyl of 1 to 4 carbon atoms, acyloxy of 1 to 4 carbon atoms; alkoxy of 1 to 4 carbon atoms; CO2H; CO2R6; NHSO2CH3; NHSO2CF3; CONHOR12; SO2NH2 ; Image ; aryl; or furyl; R3 is H; Cl, Br, I or F; alkyl of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; R4 is CN, NO2 or CO2R11; R5 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms alkenyl or alkynyl of 2 to 4 carbon atoms; R6 is alkyl of 2 to 10 carbon atoms, alkenyl or alkynyl of 3 to 10 carbon atoms or the same groups substituted with F or CO2R14; cycloalkyl of 3 to 8 carbon atoms, cycloalkylalkyl of 4 to 10 carbon atoms; cycloalkylalkenyl or cycloalkylalkynyl of 5 to 10 carbon atoms; (CH2)sZ(CH2)mR5 optionally substituted with F or CO2R14; benzyl or benzrl substituted on the phenyl ring with 1 or 2 halogens, alkoxy of 1 to 4 carbon atoms, alkyl of 1 to 4 carbon atoms or nitro; R7 is H, F, Cl, Br, I, NO2, CvF2v+1, where v =1-6, C6F5; CN; Image ; straight or branched alkyl of 1 to 6 carbon atoms; phenyl or phenylalkyl, where alkyl is 1 to 3 carbon atoms; or substituted phenyl or substituted phenylalkyl, where alkyl is 1 to 3 carbon atoms, substituted with one or two substituents selected from alkyl of 1 to 4 carbon atoms, F, Cl, Br, OH, OCH3, CF3, and COOR, where R is H, alkyl of 1 to 4 carbon atoms, or phenyl; R8 is H, CN, alkyl of 1 to 10 carbon atoms, alkenyl of 3 to 10 carbon atoms, or the same groups substituted with F; phenylalkenyl wherein the aliphatic portion is 2 to 6 carbon atoms; -(CH2)m-imidazol-1-yl; -(CH2)m-1,2,3-triazolyl optionally substituted with one or two groups selected from CO2CH3 or alkyl of 1 to 4 carbon atoms; -(CH2)s-tetrazolyl; Image ; Image ; -(CH2)nSR15 ; Image ; Image ; <IGM> ; Image ; Image ; Image ; Image ; Image ; Image ; -(CH2)nNR11SO2R10 ; Image ; -(CH2)mF ; -(CH2)mONO2; -CH2N3; -(CH2)mNO2; -CH=N-NR11R17; Image ; Image ; Image ; Image ; Image ; Image ; or Image ; R9 is Image ; R10 is alkyl of 1 to 6 carbon atoms or perfluoroalkyl of 1 to carbon atoms, 1-adamantyl, 1-naphthyl, 1-(1-naphthyl)ethyl, or (CH2)pC6H5; R11 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, phenyl or benzyl; R12 is H methyl or benzyl; R13 is -CO2H; -CO2R ; -CH2CO2H, -CH2CO2R9; Image ; Image ; -SO3H; Image -PO3H; -C(CF3)2OH; -NHSO2CH3; -NHSO2CF3; -NHCOCF3; -CONHOR12; -SO2NH2; Image ; Image ; Image ; Image ; -CONHNHSO2CF3 ; Image ; or Image ; R14 is H, alkyl or perfluoroalkyl of 1 to 8 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, phenyl or benzyl; R15 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, phenyl, benzyl, acyl of 1 to 4 carbon atoms, phenacyl; R16 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH2)pC6H5, OR17, or NR18R19; R17 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, phenyl or benzyl; R18 and R19 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl, .alpha.-methylbenzyl, or taken together with the nitrogen form a ring of the formula Image ; Q is NR20, O or CH2; R20 is H, alkyl of 1-4 carbon atoms, or phenyl; R21 is alkyl of 1 to 6 carbon atoms, -NR22R23, or Image ; R22 and R23 independently are H, alkyl of 1 to 6 carbon atoms, benzyl, or are taken together as (CH2)u where u is 3-6; R24 is H, CH3 or -C6H5; R25 is NR27R28, OR28, NHCONH2, NHCSNH2, Image or Image : R26 is hydrogen, alkyl with from 1 to 6 carbon atoms, benzyl, or allyl; R27 and R28 are independently hydrogen, alkyl with from 1 to 5 carbon atoms, or phenyl; R29 and R30 are independently alkyl of 1-4 carbon atoms or taken together are -(CH2)q-; R31 is H, alkyl of 1 to 4 carbon atoms, -CH2CH=CH2 or -CH2C6H4R32; R32 is H, NO2, NH2, OH or OCH3; X is a carbon-carbon sing-lo bond, -CO-, -CH2-, -O-, -S-, -NH-, Image , Image , Image , -OCH2-, -CH2O-, -SCH2-, -CH2S-, -NHC(R27)(R28), -NR23SO2-, -SO2NR23-, -C(R27)(R28)NH-, -CH=CH-, -CF=CF-, -CH=CF-, -CF=CH-. -CH2CH2-, -CF2CF2, Image , Image , Image , Image or Image ; Y is 0 or S; Z is 0, NR11, or S; m is 1 to 5; n is 1 to 10; p is 0 to 3; q is 2 to 3; r is 0 to 2; s is 0 to 5; t is 0 or 1; and pharmaceutically acceptable salts of these compounds; provided that: (1) the R1 group is not in the ortho position; (2) when R1 is Image , Y is a single bond, and R13 is CO2H, or Image then R13 must be in the ortho or meta position; or when R1 and X are as above and R13 is NHSO2CF3 or NHSO2CH3, R13 must be ortho; (3) when R1 is Image , and X is other than a single bond, then R13 must bo ortho except when X = NR23CO and R13 is NHSO2CF3 or NHSO2CH3, then R13 must be ortho or meta; (4) when R1 is 4-CO2H or a salt thereof, R6 cannot be S-alkyl; (5) when R1 is 4-CO2H or a salt theroof, the substituent on the 4-position of the imidazolo cannot be CH2OH, CH2OCOCH3, or CH2CO2H; (6) when R1 is Image . X -OCH2-, and R13 is 2-CO2H, nd R7 is h thcn R6 is not C2H5S; (7) when R1 is Image , and R6 is n-hexyl then R7 and R8 are not both hydrogen; (8) when R1 is Image , R6 is not methoxy- benzyl; (9) the R6 group is not Image or CH2OH; (10) when r=O, R1 is Image , X is Image R13 is 2-NHSO2CF3, and R6 is n-propyl, then R7 and R8 are not -CO2CH3; (11) when r=O, R1 is Image , X is Image , R13 is 2-COOH, and R6 is n-propyl, then R7 and R8 are not -CO2CH3; (12) when r=1, R1= Image , X is a single bond, R7 is Cl, and R8 is -CHO, then R13 is not 3-(tetrazol-5-yl); (13) when r=1, R1= Image , X is a single bond, R7 is Cl, and R8 is -CHO, then R13 is not 4-(tetrazol-5-yl).

586904

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Angiotensin ii receptor blocking imidazoles and combinations... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiotensin ii receptor blocking imidazoles and combinations..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin ii receptor blocking imidazoles and combinations... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1241230

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.